IP Library Granted Patent US 7,662,594
Granted Patent B2
US 7,662,594 · App. 11/327,175 · Granted Feb 16, 2010

Helicase-dependent amplification of RNA

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,662,594
App. No.
11/327,175
Granted
Feb 16, 2010
Kind
B2
Abstract

Methods and a kit are provided for selectively and exponentially amplifying nucleic acids and include the use of a single strand helicase preparation or a thermostable helicase in the absence of a single strand binding protein and a DNA polymerase such that the amplification can be performed isothermally.

Claims (8)

1. A method for helicase-dependent amplification of an RNA, comprising:

(a) adding to the RNA, a mixture comprising a reverse transcriptase, a helicase and a single strand binding protein unless the helicase is a thermostable helicase in which case the single strand binding protein is not required, a plurality of oligonucleotide primers and one or more polymerases; and (b) in the mixture, reverse transcribing the RNA to form a cDNA and amplifying, by helicase-dependent amplification, the cDNA wherein the amplification does not occur in the absence of the helicase as determined by gel electrophoresis.

2. A method according to claim 1 , wherein the helicase preparation comprises a UVrD helicase or homolog thereof.

3. A method according to claim 2 , wherein the UVrD helicase is a thermostable helicase.

4. A method according to claim 1 , wherein the helicase-dependent amplification is isothermal.

5. A method according to claim 4 , wherein the isothermal amplification occurs at a temperature in the range of 20° C.-75° C.

6. A method according to claim 1 , wherein the polymerase is Bst polymerase.

7. A method according to claim 1 , wherein the mixture further comprises an accessory protein.

Assignments (7)
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: BIOHELIX CORPORATION
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0661 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION
Reel/Frame 060220/0649 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Oct 6, 2017
From: QUIDEL CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 044141/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2013
From: NEW ENGLAND BIOLABS, INC.
To: BIOHELIX CORPORATION
Reel/Frame 031418/0645 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2006
From: KONG, HUIMIN; VINCENT, MYRIAM; XU, YAN; TANG, WEN
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 017690/0301 →